Takashi Kadowaki
Overview
Explore the profile of Takashi Kadowaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
777
Citations
31037
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kadowaki T, Kiyosue A, Shingaki T, Oura T, Yokote K
Lancet Diabetes Endocrinol
. 2025 Mar;
PMID: 40031941
Background: Data on tirzepatide in Asian patients with obesity are limited. This study aimed to gain a better understanding of tirzepatide for treatment of Japanese patients with obesity disease (BMI...
2.
Aranishi T, Igarashi A, Hara K, Osumili B, Cai Z, Mizogaki A, et al.
Diabetes Ther
. 2025 Feb;
16(3):447.
PMID: 39918684
No abstract available.
3.
Ikeda I, Igarashi R, Fujihara K, Takeda Y, Ferreira E, Mon K, et al.
Mayo Clin Proc
. 2025 Feb;
PMID: 39895435
Objective: To examine the association between a positive family history (parents, siblings, and grandparents) of type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia and their prevalence and incidence in the...
4.
Kadowaki T, Lee S, Ogawa W, Nishida T, Overvad M, Tobe K, et al.
Obes Res Clin Pract
. 2025 Jan;
18(6):457-464.
PMID: 39824696
Objective: To explore the effects of semaglutide versus placebo on body weight (BW) by subgroups of baseline characteristics. Methods: In STEP 6, Japanese and Korean adults with overweight or obesity...
5.
Rubino F, Cummings D, Eckel R, Cohen R, Wilding J, Brown W, et al.
Lancet Diabetes Endocrinol
. 2025 Jan;
13(3):221-262.
PMID: 39824205
No abstract available.
6.
Arakawa N, Aoyama T, Suwanai H, Toda G, Takamoto I, Okazaki Y, et al.
J Diabetes Investig
. 2024 Dec;
PMID: 39714319
Aims: Diabetic chorea refers to sudden involuntary movements developing in people with diabetes mellitus and is known to occur mainly in those with severe hyperglycemia. We conducted a questionnaire survey...
7.
Aranishi T, Igarashi A, Hara K, Osumili B, Cai Z, Mizogaki A, et al.
Diabetes Ther
. 2024 Dec;
16(3):431-445.
PMID: 39708085
Introduction: This analysis aimed to evaluate the long-term cost-effectiveness of tirzepatide 5 mg versus dulaglutide 0.75 mg (both administered once weekly) in people not achieving glycemic control on metformin, based...
8.
Okada A, Yamana H, Watanabe H, Manaka K, Ono S, Kurakawa K, et al.
Clin Kidney J
. 2024 Dec;
17(12):sfae319.
PMID: 39664986
Background And Hypothesis: We aimed to evaluate the diagnostic validity of the International Classification of Diseases, 10th Revision (ICD-10) codes for hyponatremia and hypernatremia, using a database containing laboratory data....
9.
Kadowaki Y, Aoyama T, Hada Y, Aihara M, Sawada M, Sekine R, et al.
Endocr J
. 2024 Nov;
72(3):307-317.
PMID: 39603654
The Japan Society for the Study of Obesity recommends a weight loss of 3% of body weight over a period of 3-6 months. However, the effects of rapid weight loss...
10.
Okada A, Aso S, Kurakawa K, Inoue R, Watanabe H, Sasabuchi Y, et al.
Clin Kidney J
. 2024 Nov;
17(11):sfae321.
PMID: 39564392
Background: Although the kidney failure risk equation (KFRE), a well-known predictive model for predicting dialysis dependency, is useful, it remains unclear whether the addition of biomarker changes to the KFRE...